Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2018, Vol. 23 ›› Issue (12): 1425-1430.doi: 10.12092/j.issn.1009-2501.2018.12.019

Previous Articles     Next Articles

Advances in studies of neurotoxicity of angiotensin(1-7)

CHEN Dan1, GUO Yujin1, YANG Mengqi1, CA Hual in 2, JIANG Pei1   

  1. 1 Department of Clinical Pharmacy, First People's Hospital of Jining, Jining 272000, Shandong, China; 2 Department of Clinical Pharmacy, the Second Xiangya Hospital of Central South University, Shangsha 410011, Hunan, China
  • Received:2018-09-05 Revised:2018-10-09 Online:2018-12-26 Published:2018-12-27

Abstract:

Angiotensin (1-7) reverse regulation of the classic ACE-AngII-AT axis through the branch of the new role of angiotensin converting enzyme ACE2-Ang (1-7) -Mas receptor axis. Ang (1-7) is widely distributed in the supraoptic and paraventricular nucleus of hypothalamus. It has effects of dilating blood vessels, anti-arrhythmia, anti-inflammatory and so on, which could protect the cardiovascular and central nervous system by affecting the synthesis and releasing other central neurotransmitters through bradykinin, nitric oxide synthase (NOS), cyclooxygenase (COX) and some signaling pathways. This paper reviews the distribution of Ang (1-7) and the diversity of the biological functions in the central nervous system.

Key words: angiotensin(1-7), renin-angiotensin system, reverse regulation, central nervous system

CLC Number: